As for the SHH-N–AR interaction that we identified, the extent of this interaction in clinical samples should be evaluated and it remains to be investigated whether its inhibition in advanced prostate cancer and CRPC could be relevant for successful treatment. The gene discussed is SHH; the disease is prostate cancer.